Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1989-8-4
|
pubmed:abstractText |
Azathioprine [Imuran; 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-purine] is a widely used immunosuppressive and antiarthritic drug. For the sake of comparison, the riboside, the 2'-deoxyriboside, and the arabinoside of azathioprine and its 2-amino congener, thiamiprine, were prepared by an enzymatic method. In vitro, the cytotoxicities of these aglycons and their nucleosides were similar (ED50 = 0.8-2 microM), except for the arabinosides, which were nontoxic (ED50 greater than 100 microM). In vivo, their activities were compared in the rat adjuvant arthritis model. The ribosides and 2'-deoxyribosides were less potent than their corresponding aglycons. The safety indexes of these nucleosides were comparable to those of the corresponding aglycons except for the 2'-deoxyriboside of azathioprine, which had an appreciably lower safety index than did azathioprine. Both arabinosides were inactive and nontoxic. All of the aglycons tested (6-mercaptopurine, azathioprine, 6-thioguanine, and thiamiprine) were of similar potency. However, azathioprine had a more favorable therapeutic index than did 6-mercaptopurine. Similarly, thiamiprine was safer than was 6-thioguanine. In this model, the S-(1-methyl-4-nitro-1H-imidazol-5-yl) moiety imparted greater safety to these thiopurines by decreasing toxicity but not affecting potency.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1471-5
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:2738881-Animals,
pubmed-meshheading:2738881-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:2738881-Arthritis, Experimental,
pubmed-meshheading:2738881-Azathioprine,
pubmed-meshheading:2738881-Cell Survival,
pubmed-meshheading:2738881-Cells, Cultured,
pubmed-meshheading:2738881-Chemical Phenomena,
pubmed-meshheading:2738881-Chemistry,
pubmed-meshheading:2738881-Disease Models, Animal,
pubmed-meshheading:2738881-Female,
pubmed-meshheading:2738881-Humans,
pubmed-meshheading:2738881-Nucleosides,
pubmed-meshheading:2738881-Rats
|
pubmed:year |
1989
|
pubmed:articleTitle |
Nucleosides of azathioprine and thiamiprine as antiarthritics.
|
pubmed:affiliation |
Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709.
|
pubmed:publicationType |
Journal Article
|